Jonathan Louw

CEO, South African National Blood Service (SANBS)

Jonathan Louw

Jonathan Louw, MB.ChB, MBA, is the CEO of the South African National Blood Service (SANBS), which caters to the entire value chain of blood donation, testing and logistics through transfusion to patients across South Africa.

Previously he was the Managing Director at The Abraaj Group, the largest private equity firm in the Middle East. He was also the Co-CEO for the Abraaj Global Healthcare Fund (in the Dubai headquarter office), raising and deploying $1bn in Hospitals and Diagnostics in global growth markets. Prior to this, Dr. Louw worked at Adcock Ingram Holdings Limited (JSE:AIP) and was the CEO and Managing Director from Jan 2003 until May 2014. Adcock Ingram is a South African Healthcare company with operations across Sub-Saharan Africa and India. It operates across branded generics, licensed multinational patented products, hospital products and consumer products with leading market shares in all categories. Dr Louw led the IPO of Adcock Ingram when it separated from the JSE-Listed TigerBrands in 2008 and during his tenure the business adopted an aggressive growth strategy, re-investing in manufacturing and R&D to achieve FDA and PIC/s accreditation in both. The distribution capability was improved through automation and successful integration of Oracle and numerous acquisitions and license agreements were consummated to diversify the business internationally and enter new fast-growing categories. He joined TigerBrands in 2001 as the New Business Development Director, overseeing the geographic expansion and spearheading acquisitions and new product development.

Dr Louw first joined the pharmaceutical industry through AstraZeneca in 2000. He was an Anesthetist at St. Mary's Hospital in London, having trained as an undergraduate at the University of Cape Town in the faculty of Medicine. He has also served as the President of the Pharmaceutical Industry Association of South Africa in 20009/10, representing the interest of local and multi-national pharmaceutical companies, and is a Board member of Generation Ubuntu (NYC) looking after Orphans afflicted with HIV/AIDS in South Africa.